Observational studyJournal of endocrinological investigation2026
Diffusion-weighted magnetic resonance imaging as a promising technique for detection and follow-up of liver metastases from neuroendocrine tumors: a retrospective and prospective study from the NETTARE task force.
Observational study in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA combination of morphological and functional imaging plays a crucial role for neuroendocrine tumors (NETs) management. Diffusion-weighted magnetic resonance imaging (DWI-MRI) is an emerging key imaging technique in the NET field.
aimto evaluate the diagnostic and prognostic role of DWI-MRI in liver metastases (LMs) from NETs compared with multiparametric MRI and functional imaging with
methodsThis is a monocentric, observational, both retrospective and prospective study including patients with histologically proven diagnosis of gastroenteropancreatic (GEP) NET with LM evaluated with MRI and
results426 LMs were analyzed from 17 patients (11 males, mean age 57.2 ± 12.6 years) meeting the inclusion criteria (11.8% G1, 64.7% G2, and 23.5% G3); MRI detected a median of 15 (IQR 2.5-40) lesions per patient, DWI 15 (IQR 2.5-36.5) lesions, while PET-CT 6 (IQR 2.5-20) lesions. Non-parametric analyses suggested that DWI had a detection rate comparable to MRI (p = 0.068) and superior to 68Ga-DOTA peptides PET-CT (p = 0.004), whereas mixed-effects modelling accounting for within-patient clustering showed no statistically significant pairwise differences between imaging modalities after multiple-comparison correction. Moderate-to-good consistency in lesion burden estimation across imaging modalities supported the reproducibility of lesion quantification. Correlation analyses suggested MRI lesion load may reflect the aggressiveness of disease.
conclusionsDWI-MRI can be a useful time-saving imaging technique in the diagnosis and follow-up of LMs from NETs, with a potentially favorable cost-effectiveness ratio.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.